<scp>l</scp> ‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma-Reference-Cited by-同舟云学术

l ‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma

Published:2022-06-27 Issue:8 Volume:36 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem & Molecular Tox

Author:

Sang Wei¹²³,Tu Dongyun¹³⁴,Zhang Meng¹³,Qin Yuanyuan¹³,Yin Wenjing¹³,Song Xuguang²,Sun Cai²,Yan Dongmei²,Wang Xiangmin²,Zeng Lingyu¹²³,Li Zhenyu¹²³,Xu Kailin¹²³,Xu Linyan¹²³^ORCID

Affiliation:

1. Blood Diseases Institute Xuzhou Medical University Xuzhou Jiangsu China

2. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu China

3. Key Laboratory of Bone Marrow Stem Cell Xuzhou Jiangsu China

4. Department of Cardiology Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine Yancheng Jiangsu China

Funder

Natural Science Foundation of Jiangsu Province

Jiangsu Planned Projects for Postdoctoral Research Funds

National Natural Science Foundation of China

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.23117

Reference48 articles.

1. Treating Burkitt Lymphoma in Adults

2. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

3. Molecular Biology of Burkitt’s Lymphoma

4. Burkitt lymphoma- a rare but challenging lymphoma

5. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substrate Affinity Is Not Crucial for Therapeutic L-Asparaginases: Antileukemic Activity of Novel Bacterial Enzymes;Molecules;2024-05-11

2. Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study;The Innovation;2023-05